Repligen (RGEN) Cash & Current Investments (2010 - 2026)

Repligen (RGEN) has reported Cash & Current Investments for 17 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash & Current Investments rose 43.06% year-over-year to $1.0 billion; the TTM figure through Jun 2026 stood at $1.0 billion (up 43.06% YoY), while the FY2025 annual figure was $969.2 million, up 27.93% from the prior year.
• Cash & Current Investments grew to $1.0 billion in Q2 2026 per RGEN's latest filing, from $986.4 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $1.0 billion in Q2 2026 and bottomed at $573.4 million in Q3 2022.
• Historically, Cash & Current Investments has averaged $735.4 million across 5 years, with a median of $728.8 million in 2025.
• Annual changes were most pronounced in 2022 — Cash & Current Investments dropped 18.77% — and 2026, when it soared 43.06%.
• Repligen's Cash & Current Investments stood at $623.8 million in 2022, then advanced by 20.45% to $751.3 million in 2023, then advanced by 0.84% to $757.6 million in 2024, then climbed by 27.93% to $969.2 million in 2025, then increased by 4.63% to $1.0 billion in 2026.
• Business Quant data shows RGEN's Cash & Current Investments at $1.0 billion in Q2 2026, $986.4 million in Q1 2026, and $969.2 million in Q4 2025.